HomeAnswersMedical oncologybreast cancer

How can I manage HR+ breast cancer at age 50?

This Premium Q&A, reviewed and published, features a real conversation between an iCliniq user and a physician.

Patient's Query

Hello doctor,

I am 50 years old, and I have just been diagnosed with HR-positive breast cancer. I am attaching my test reports for your reference. My doctor suggests hormone therapy, but I am not sure if I need chemotherapy, too. My mom had breast cancer at 65.

  1. What are my five-year and 10-year survival chances?

  2. What is my risk of the cancer coming back?

  3. What are the side effects of different treatments?

  4. Can you help me understand my situation better and maybe suggest ways to improve my odds while keeping a good quality of life?

Kindly help.

Thank you.

Answered by Dr. Arshad Hussain Shah

Education:

MD

Professional Bio:

Dr. Arshad Hussain Shah is a Medical Oncologist specializing in the diagnosis and treatment of cancer using chemotherapy, targeted therapy, and immunotherapy. He is dedicated to providing personalized, evidence-based care that supports patients through all stages of cancer treatment while improving their quality of life.

This doctor is not available for online consultations on the platform anymore.

Hello,

Welcome to icliniq.com.

I read your query.

I went through your reports (attachments removed to protect the patient's identity). I can understand your concern. It looks like your breast cancer is at an early stage, and this type of breast cancer usually has a good prognosis.

Your recurrence score is also low, so there is very little chance of recurrence after the completion of treatment. You may benefit from hormonal therapy alone, but some more tests may be needed, and I need to see your histopathology report and BRCA (breast cancer) status. Hormonal treatment has fewer side effects, including bone loss, musculoskeletal pain, endometrial pathology, etc., depending upon the type of hormone treatment.

While chemotherapy has many side effects, most of them are manageable with medicines. Overall, with this stage and hormone-positive breast cancer, the prognosis is excellent, with a 10-year survival rate of more than 80 percent.

Revert with the answer to assist further.

Thank you, and take care.

Medically reviewed by iCliniq medical review team
Published At September 23, 2024
Reviewed At June 11, 2026

Education:

MD

Professional Bio:

Dr. Arshad Hussain Shah is a Medical Oncologist specializing in the diagnosis and treatment of cancer using chemotherapy, targeted therapy, and immunotherapy. He is dedicated to providing personalized, evidence-based care that supports patients through all stages of cancer treatment while improving their quality of life.

This doctor is not available for online consultations on the platform anymore.

Same symptoms don't mean you have the same problem. Consult a doctor now!

Education:

MD

Professional Bio:

Dr. Arshad Hussain Shah is a Medical Oncologist specializing in the diagnosis and treatment of cancer using chemotherapy, targeted therapy, and immunotherapy. He is dedicated to providing personalized, evidence-based care that supports patients through all stages of cancer treatment while improving their quality of life.

This doctor is not available for online consultations on the platform anymore.

Listen to related tracks in our music library
Comprehensive Second Opinion

Read answers about:

hormone therapybreast cancer

Ask your health query to a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.